Literature DB >> 27022728

Combination treatment with herbal medicines and Western medicines in atopic dermatitis: Benefits and considerations.

Jung-Hoon Kim1, Hyungwoo Kim2.   

Abstract

Herbal medicines (HMs) are often used in combination with Western medicines (WMs) to improve therapeutic efficacies of orthodox medicines. This review discussed the current status of combination treatment with HMs and WMs in clinical practices. The influence of HMs on bioavailability of WMs was also discussed from the pharmacokinetic point of view. In addition, benefits and considerations of combination treatment were discussed using data obtained from clinical trials and randomized controlled trials of HMs treatment in skin diseases.

Entities:  

Keywords:  atopic dermatitis; combination treatment; herbal medicine; pharmacokinetics; psoriasis

Mesh：

Substances：

Year:  2016        PMID： 27022728     DOI： 10.1007/s11655-016-2099-0

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN： 1672-0415            Impact factor:   1.978


  24 in total

1.  Efficacy of traditional Chinese herbal therapy in adult atopic dermatitis.

Authors:  M P Sheehan; M H Rustin; D J Atherton; C Buckley; D W Harris; J Brostoff; L Ostlere; A Dawson; D J Harris
Journal:  Lancet       Date:  1992-07-04       Impact factor: 79.321

2.  Efficacy of a novel herbal multicomponent traditional Chinese medicine therapy approach in patients with atopic dermatitis.

Authors:  Songhua Li; Kenny Kuchta; Naomi Tamaru; Yu Lin; Sumio Iwasaki; Ruwei Wang; Yuta Kobayashi; Hans Wilhelm Rauwald; Tsutomu Kamei
Journal:  Forsch Komplementmed       Date:  2013-06-24

3.  The effects of ephedrine and theophylline on dexamethasone metabolism in bronchial asthma.

Authors:  S M Brooks; L J Sholiton; E E Werk; P Altenau
Journal:  J Clin Pharmacol       Date:  1977 May-Jun       Impact factor: 3.126

Review 4.  Chinese herbal medicine for atopic eczema.

Authors:  Sherman Gu; Angela W H Yang; Charlie C L Xue; Chun G Li; Carmen Pang; Weiya Zhang; Hywel C Williams
Journal:  Cochrane Database Syst Rev       Date:  2013-09-10

5.  A population physiologically based pharmacokinetic/pharmacodynamic model for the inhibition of 11-beta-hydroxysteroid dehydrogenase activity by glycyrrhetic acid.

Authors:  B Ploeger; T Mensinga; A Sips; C Deerenberg; J Meulenbelt; J DeJongh
Journal:  Toxicol Appl Pharmacol       Date:  2001-01-01       Impact factor: 4.219

6.  A controlled trial of traditional Chinese medicinal plants in widespread non-exudative atopic eczema.

Authors:  M P Sheehan; D J Atherton
Journal:  Br J Dermatol       Date:  1992-02       Impact factor: 9.302

7.  Effect of oral administration of glycyrrhizin on the pharmacokinetics of prednisolone.

Authors:  M F Chen; F Shimada; H Kato; S Yano; M Kanaoka
Journal:  Endocrinol Jpn       Date:  1991-04

8.  Down-regulation of a hepatic transporter multidrug resistance-associated protein 2 is involved in alteration of pharmacokinetics of glycyrrhizin and its metabolites in a rat model of chronic liver injury.

Authors:  Toshiaki Makino; Nobuhiro Ohtake; Akito Watanabe; Naoko Tsuchiya; Sachiko Imamura; Seiichi Iizuka; Makoto Inoue; Hajime Mizukami
Journal:  Drug Metab Dispos       Date:  2008-03-24       Impact factor: 3.922

9.  Kinetics and dynamics of orally administered 18 beta-glycyrrhetinic acid in humans.

Authors:  S Krähenbühl; F Hasler; B M Frey; F J Frey; R Brenneisen; R Krapf
Journal:  J Clin Endocrinol Metab       Date:  1994-03       Impact factor: 5.958

10.  Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid.

Authors:  S Teelucksingh; A D Mackie; D Burt; M A McIntyre; L Brett; C R Edwards
Journal:  Lancet       Date:  1990-05-05       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.